You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 259 No. 19, May 20, 1988 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Oral Acyclovir for Treatment of First-Episode Herpes Simplex Virus Proctitis

Ann M. Rompalo, MD; Gregory J. Mertz, MD; L. Gray Davis, MS; Jacqueline Benedetti, PhD; Cathy Critchlow, MS; Walter E. Stamm, MD; Lawrence Corey, MD

JAMA. 1988;259(19):2879-2881.


Abstract

Twenty-nine patients with first-episode rectal herpes simplex virus infection were enrolled in a double-blind trial of oral acyclovir, 400 mg five times daily, vs placebo treatment. Eighty percent of those receiving acyclovir compared with 25% of placebo recipients no longer had herpes simplex virus isolated from their rectal lesions three days after onset of therapy. The median duration of rectal lesions and viral excretion from rectal lesions (median, five and zero days, respectively) was significantly shorter in patients treated with acyclovir than in placebo-treated patients (14 and 11 days, respectively). Durations of local signs and symptoms of proctitis, such as rectal pain, discharge, and friability, were shorter in acyclovir recipients than in placebo recipients, but these differences were not statistically significant. Daily administration of 2 g of oral acyclovir for ten days alleviates some of the clinical signs of herpes simplex virus rectal infection.

(JAMA 1988;259:2879-2881)



Author Affiliations

From the Departments of Medicine (Drs Rompalo, Mertz, Benedetti, Stamm, and Corey and Ms Critchlow), Laboratory Medicine (Drs Mertz and Corey), and Microbiology (Dr Corey), School of Medicine, and the Department of Biostatistics, School of Public Health and Community Medicine (Dr Benedetti and Ms Critchlow), University of Washington, Seattle; and the Burroughs Wellcome Company, Research Triangle Park, NC (Mr Davis). Dr Mertz is now with the Department of Medicine, University of New Mexico School of Medicine, Albuquerque.


Footnotes

Reprints not available.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Sexually transmitted proctitis
Hamlyn and Taylor
Postgrad. Med. J. 2006;82:733-736.
ABSTRACT | FULL TEXT  

ORAL ACYCLOVIR SPEEDS RESOLUTION OF HERPES PROCTITIS
JWatch General 1988;1988:5-5.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.